ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PEG-modified Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11I15418
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PEG modified Drugs Market Research Report 2023
BUY CHAPTERS

Global PEG-modified Drugs Market Research Report 2025

Code: QYRE-Auto-11I15418
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck Sharp & Dohme
Baxalta
Amgen Inc
UCB
Enzon, Inc.
Horizon Pharma Plc
Biogen
Changchun Genescience Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd
SUNBIO
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd.
Hansoh Pharmaceuticak Group Co.,Ltd.
Xiamen Sano banger Biotechnology Co., Ltd
Roche
Qilu Pharmaceutical Co. Ltd.

PEG-modified Drugs Market

The global market for PEG-modified Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Polyethylene glycol modified drug refers to a method of drug modification that combines polyethylene glycol molecules with drug molecules to improve the properties, pharmacokinetics and pharmacodynamic properties of drugs. This modification is often used to improve drug solubility, stability, bioavailability, and drug distribution.
North American market for PEG-modified Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PEG-modified Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for PEG-modified Drugs in Cancer Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of PEG-modified Drugs include Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc., Qilu Pharmaceutical Co., Ltd., CSPC Baike (Shandong) Biopharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PEG-modified Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEG-modified Drugs.
The PEG-modified Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PEG-modified Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEG-modified Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PEG-modified Drugs Market Report

Report Metric Details
Report Name PEG-modified Drugs Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc., Qilu Pharmaceutical Co., Ltd., CSPC Baike (Shandong) Biopharmaceutical Co., Ltd., Changchun Genescience Pharmaceutical Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Hansoh Pharmaceuticak Group Co.,Ltd., SunBio, Xiamen Sano banger Biotechnology Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PEG-modified Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PEG-modified Drugs Market report?

Ans: The main players in the PEG-modified Drugs Market are Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc., Qilu Pharmaceutical Co., Ltd., CSPC Baike (Shandong) Biopharmaceutical Co., Ltd., Changchun Genescience Pharmaceutical Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Hansoh Pharmaceuticak Group Co.,Ltd., SunBio, Xiamen Sano banger Biotechnology Co., Ltd

What are the Application segmentation covered in the PEG-modified Drugs Market report?

Ans: The Applications covered in the PEG-modified Drugs Market report are Cancer Treatment, Diabetes Treatment, Immunomodulatory, Anti-inflammatory Treatment, Others

What are the Type segmentation covered in the PEG-modified Drugs Market report?

Ans: The Types covered in the PEG-modified Drugs Market report are PEG Amidation, PEGylation, PEG Peptidation, PEG Etherification, Other Combinations

Recommended Reports

Polyethylene Glycol Markets

PEGylated Pharmaceuticals

Drug Delivery Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEG-modified Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PEG Amidation
1.2.3 PEGylation
1.2.4 PEG Peptidation
1.2.5 PEG Etherification
1.2.6 Other Combinations
1.3 Market by Application
1.3.1 Global PEG-modified Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Treatment
1.3.3 Diabetes Treatment
1.3.4 Immunomodulatory
1.3.5 Anti-inflammatory Treatment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEG-modified Drugs Market Perspective (2020-2031)
2.2 Global PEG-modified Drugs Growth Trends by Region
2.2.1 Global PEG-modified Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PEG-modified Drugs Historic Market Size by Region (2020-2025)
2.2.3 PEG-modified Drugs Forecasted Market Size by Region (2026-2031)
2.3 PEG-modified Drugs Market Dynamics
2.3.1 PEG-modified Drugs Industry Trends
2.3.2 PEG-modified Drugs Market Drivers
2.3.3 PEG-modified Drugs Market Challenges
2.3.4 PEG-modified Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PEG-modified Drugs Players by Revenue
3.1.1 Global Top PEG-modified Drugs Players by Revenue (2020-2025)
3.1.2 Global PEG-modified Drugs Revenue Market Share by Players (2020-2025)
3.2 Global PEG-modified Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PEG-modified Drugs Revenue
3.4 Global PEG-modified Drugs Market Concentration Ratio
3.4.1 Global PEG-modified Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEG-modified Drugs Revenue in 2024
3.5 Global Key Players of PEG-modified Drugs Head office and Area Served
3.6 Global Key Players of PEG-modified Drugs, Product and Application
3.7 Global Key Players of PEG-modified Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PEG-modified Drugs Breakdown Data by Type
4.1 Global PEG-modified Drugs Historic Market Size by Type (2020-2025)
4.2 Global PEG-modified Drugs Forecasted Market Size by Type (2026-2031)
5 PEG-modified Drugs Breakdown Data by Application
5.1 Global PEG-modified Drugs Historic Market Size by Application (2020-2025)
5.2 Global PEG-modified Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PEG-modified Drugs Market Size (2020-2031)
6.2 North America PEG-modified Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PEG-modified Drugs Market Size by Country (2020-2025)
6.4 North America PEG-modified Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PEG-modified Drugs Market Size (2020-2031)
7.2 Europe PEG-modified Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PEG-modified Drugs Market Size by Country (2020-2025)
7.4 Europe PEG-modified Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PEG-modified Drugs Market Size (2020-2031)
8.2 Asia-Pacific PEG-modified Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PEG-modified Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific PEG-modified Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PEG-modified Drugs Market Size (2020-2031)
9.2 Latin America PEG-modified Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PEG-modified Drugs Market Size by Country (2020-2025)
9.4 Latin America PEG-modified Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PEG-modified Drugs Market Size (2020-2031)
10.2 Middle East & Africa PEG-modified Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PEG-modified Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa PEG-modified Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Company Details
11.1.2 Merck Sharp & Dohme Business Overview
11.1.3 Merck Sharp & Dohme PEG-modified Drugs Introduction
11.1.4 Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2020-2025)
11.1.5 Merck Sharp & Dohme Recent Development
11.2 Baxalta Inc.
11.2.1 Baxalta Inc. Company Details
11.2.2 Baxalta Inc. Business Overview
11.2.3 Baxalta Inc. PEG-modified Drugs Introduction
11.2.4 Baxalta Inc. Revenue in PEG-modified Drugs Business (2020-2025)
11.2.5 Baxalta Inc. Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Details
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. PEG-modified Drugs Introduction
11.3.4 Amgen Inc. Revenue in PEG-modified Drugs Business (2020-2025)
11.3.5 Amgen Inc. Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PEG-modified Drugs Introduction
11.4.4 Roche Revenue in PEG-modified Drugs Business (2020-2025)
11.4.5 Roche Recent Development
11.5 UCB S.A.
11.5.1 UCB S.A. Company Details
11.5.2 UCB S.A. Business Overview
11.5.3 UCB S.A. PEG-modified Drugs Introduction
11.5.4 UCB S.A. Revenue in PEG-modified Drugs Business (2020-2025)
11.5.5 UCB S.A. Recent Development
11.6 Enzon
11.6.1 Enzon Company Details
11.6.2 Enzon Business Overview
11.6.3 Enzon PEG-modified Drugs Introduction
11.6.4 Enzon Revenue in PEG-modified Drugs Business (2020-2025)
11.6.5 Enzon Recent Development
11.7 Horizon Pharma Plc
11.7.1 Horizon Pharma Plc Company Details
11.7.2 Horizon Pharma Plc Business Overview
11.7.3 Horizon Pharma Plc PEG-modified Drugs Introduction
11.7.4 Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2020-2025)
11.7.5 Horizon Pharma Plc Recent Development
11.8 Biogen Inc.
11.8.1 Biogen Inc. Company Details
11.8.2 Biogen Inc. Business Overview
11.8.3 Biogen Inc. PEG-modified Drugs Introduction
11.8.4 Biogen Inc. Revenue in PEG-modified Drugs Business (2020-2025)
11.8.5 Biogen Inc. Recent Development
11.9 Qilu Pharmaceutical Co., Ltd.
11.9.1 Qilu Pharmaceutical Co., Ltd. Company Details
11.9.2 Qilu Pharmaceutical Co., Ltd. Business Overview
11.9.3 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.9.4 Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.9.5 Qilu Pharmaceutical Co., Ltd. Recent Development
11.10 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
11.10.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Details
11.10.2 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
11.10.3 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.10.4 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.10.5 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Development
11.11 Changchun Genescience Pharmaceutical Co., Ltd.
11.11.1 Changchun Genescience Pharmaceutical Co., Ltd. Company Details
11.11.2 Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
11.11.3 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.11.4 Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.11.5 Changchun Genescience Pharmaceutical Co., Ltd. Recent Development
11.12 Xiamen Amoytop Biotech Co., Ltd.
11.12.1 Xiamen Amoytop Biotech Co., Ltd. Company Details
11.12.2 Xiamen Amoytop Biotech Co., Ltd. Business Overview
11.12.3 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Introduction
11.12.4 Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.12.5 Xiamen Amoytop Biotech Co., Ltd. Recent Development
11.13 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.13.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Details
11.13.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
11.13.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Introduction
11.13.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
11.14 Hansoh Pharmaceuticak Group Co.,Ltd.
11.14.1 Hansoh Pharmaceuticak Group Co.,Ltd. Company Details
11.14.2 Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
11.14.3 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Introduction
11.14.4 Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2020-2025)
11.14.5 Hansoh Pharmaceuticak Group Co.,Ltd. Recent Development
11.15 SunBio
11.15.1 SunBio Company Details
11.15.2 SunBio Business Overview
11.15.3 SunBio PEG-modified Drugs Introduction
11.15.4 SunBio Revenue in PEG-modified Drugs Business (2020-2025)
11.15.5 SunBio Recent Development
11.16 Xiamen Sano banger Biotechnology Co., Ltd
11.16.1 Xiamen Sano banger Biotechnology Co., Ltd Company Details
11.16.2 Xiamen Sano banger Biotechnology Co., Ltd Business Overview
11.16.3 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Introduction
11.16.4 Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2020-2025)
11.16.5 Xiamen Sano banger Biotechnology Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck Sharp & Dohme
Baxalta
Amgen Inc
UCB
Enzon, Inc.
Horizon Pharma Plc
Biogen
Changchun Genescience Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd
SUNBIO
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd.
Hansoh Pharmaceuticak Group Co.,Ltd.
Xiamen Sano banger Biotechnology Co., Ltd
Roche
Qilu Pharmaceutical Co. Ltd.
List of Tables
 Table 1. Global PEG-modified Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PEG Amidation
 Table 3. Key Players of PEGylation
 Table 4. Key Players of PEG Peptidation
 Table 5. Key Players of PEG Etherification
 Table 6. Key Players of Other Combinations
 Table 7. Global PEG-modified Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global PEG-modified Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global PEG-modified Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global PEG-modified Drugs Market Share by Region (2020-2025)
 Table 11. Global PEG-modified Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global PEG-modified Drugs Market Share by Region (2026-2031)
 Table 13. PEG-modified Drugs Market Trends
 Table 14. PEG-modified Drugs Market Drivers
 Table 15. PEG-modified Drugs Market Challenges
 Table 16. PEG-modified Drugs Market Restraints
 Table 17. Global PEG-modified Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global PEG-modified Drugs Market Share by Players (2020-2025)
 Table 19. Global Top PEG-modified Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2024)
 Table 20. Ranking of Global Top PEG-modified Drugs Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by PEG-modified Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of PEG-modified Drugs, Headquarters and Area Served
 Table 23. Global Key Players of PEG-modified Drugs, Product and Application
 Table 24. Global Key Players of PEG-modified Drugs, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global PEG-modified Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global PEG-modified Drugs Revenue Market Share by Type (2020-2025)
 Table 28. Global PEG-modified Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global PEG-modified Drugs Revenue Market Share by Type (2026-2031)
 Table 30. Global PEG-modified Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global PEG-modified Drugs Revenue Market Share by Application (2020-2025)
 Table 32. Global PEG-modified Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global PEG-modified Drugs Revenue Market Share by Application (2026-2031)
 Table 34. North America PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America PEG-modified Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America PEG-modified Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe PEG-modified Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe PEG-modified Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific PEG-modified Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific PEG-modified Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific PEG-modified Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America PEG-modified Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America PEG-modified Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa PEG-modified Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa PEG-modified Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Merck Sharp & Dohme Company Details
 Table 50. Merck Sharp & Dohme Business Overview
 Table 51. Merck Sharp & Dohme PEG-modified Drugs Product
 Table 52. Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 53. Merck Sharp & Dohme Recent Development
 Table 54. Baxalta Inc. Company Details
 Table 55. Baxalta Inc. Business Overview
 Table 56. Baxalta Inc. PEG-modified Drugs Product
 Table 57. Baxalta Inc. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 58. Baxalta Inc. Recent Development
 Table 59. Amgen Inc. Company Details
 Table 60. Amgen Inc. Business Overview
 Table 61. Amgen Inc. PEG-modified Drugs Product
 Table 62. Amgen Inc. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 63. Amgen Inc. Recent Development
 Table 64. Roche Company Details
 Table 65. Roche Business Overview
 Table 66. Roche PEG-modified Drugs Product
 Table 67. Roche Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 68. Roche Recent Development
 Table 69. UCB S.A. Company Details
 Table 70. UCB S.A. Business Overview
 Table 71. UCB S.A. PEG-modified Drugs Product
 Table 72. UCB S.A. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 73. UCB S.A. Recent Development
 Table 74. Enzon Company Details
 Table 75. Enzon Business Overview
 Table 76. Enzon PEG-modified Drugs Product
 Table 77. Enzon Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 78. Enzon Recent Development
 Table 79. Horizon Pharma Plc Company Details
 Table 80. Horizon Pharma Plc Business Overview
 Table 81. Horizon Pharma Plc PEG-modified Drugs Product
 Table 82. Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 83. Horizon Pharma Plc Recent Development
 Table 84. Biogen Inc. Company Details
 Table 85. Biogen Inc. Business Overview
 Table 86. Biogen Inc. PEG-modified Drugs Product
 Table 87. Biogen Inc. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 88. Biogen Inc. Recent Development
 Table 89. Qilu Pharmaceutical Co., Ltd. Company Details
 Table 90. Qilu Pharmaceutical Co., Ltd. Business Overview
 Table 91. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product
 Table 92. Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 93. Qilu Pharmaceutical Co., Ltd. Recent Development
 Table 94. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Details
 Table 95. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
 Table 96. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product
 Table 97. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 98. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Development
 Table 99. Changchun Genescience Pharmaceutical Co., Ltd. Company Details
 Table 100. Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
 Table 101. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product
 Table 102. Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 103. Changchun Genescience Pharmaceutical Co., Ltd. Recent Development
 Table 104. Xiamen Amoytop Biotech Co., Ltd. Company Details
 Table 105. Xiamen Amoytop Biotech Co., Ltd. Business Overview
 Table 106. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product
 Table 107. Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 108. Xiamen Amoytop Biotech Co., Ltd. Recent Development
 Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Details
 Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
 Table 111. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product
 Table 112. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 113. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
 Table 114. Hansoh Pharmaceuticak Group Co.,Ltd. Company Details
 Table 115. Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
 Table 116. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product
 Table 117. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 118. Hansoh Pharmaceuticak Group Co.,Ltd. Recent Development
 Table 119. SunBio Company Details
 Table 120. SunBio Business Overview
 Table 121. SunBio PEG-modified Drugs Product
 Table 122. SunBio Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 123. SunBio Recent Development
 Table 124. Xiamen Sano banger Biotechnology Co., Ltd Company Details
 Table 125. Xiamen Sano banger Biotechnology Co., Ltd Business Overview
 Table 126. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product
 Table 127. Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2020-2025) & (US$ Million)
 Table 128. Xiamen Sano banger Biotechnology Co., Ltd Recent Development
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources
 Table 132. Authors List of This Report


List of Figures
 Figure 1. PEG-modified Drugs Picture
 Figure 2. Global PEG-modified Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PEG-modified Drugs Market Share by Type: 2024 VS 2031
 Figure 4. PEG Amidation Features
 Figure 5. PEGylation Features
 Figure 6. PEG Peptidation Features
 Figure 7. PEG Etherification Features
 Figure 8. Other Combinations Features
 Figure 9. Global PEG-modified Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global PEG-modified Drugs Market Share by Application: 2024 VS 2031
 Figure 11. Cancer Treatment Case Studies
 Figure 12. Diabetes Treatment Case Studies
 Figure 13. Immunomodulatory Case Studies
 Figure 14. Anti-inflammatory Treatment Case Studies
 Figure 15. Others Case Studies
 Figure 16. PEG-modified Drugs Report Years Considered
 Figure 17. Global PEG-modified Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global PEG-modified Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global PEG-modified Drugs Market Share by Region: 2024 VS 2031
 Figure 20. Global PEG-modified Drugs Market Share by Players in 2024
 Figure 21. Global Top PEG-modified Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by PEG-modified Drugs Revenue in 2024
 Figure 23. North America PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America PEG-modified Drugs Market Share by Country (2020-2031)
 Figure 25. United States PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe PEG-modified Drugs Market Share by Country (2020-2031)
 Figure 29. Germany PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific PEG-modified Drugs Market Share by Region (2020-2031)
 Figure 37. China PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America PEG-modified Drugs Market Share by Country (2020-2031)
 Figure 45. Mexico PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa PEG-modified Drugs Market Share by Country (2020-2031)
 Figure 49. Turkey PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE PEG-modified Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Merck Sharp & Dohme Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 53. Baxalta Inc. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 54. Amgen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 56. UCB S.A. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 57. Enzon Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 58. Horizon Pharma Plc Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 59. Biogen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 60. Qilu Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 61. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 62. Changchun Genescience Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 63. Xiamen Amoytop Biotech Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 64. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 65. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 66. SunBio Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 67. Xiamen Sano banger Biotechnology Co., Ltd Revenue Growth Rate in PEG-modified Drugs Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Polyethylene Glycol PEG Modification Technology Market Research Report 2024
Global PEG modified Drugs Recombinant Proteins Polypeptides Market Research Report 2024
Global PEGylation Technology Market Research Report 2024
Global Pharmaceutical Polyethylene Glycol Market Research Report 2025
Global Implantable Polyethylene Glycol PEG Material Market Research Report 2024
Global Injectable Polyethylene Glycol PEG Material Market Research Report 2024
PEGylation Proteins Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Functionalized Polyethylene Glycol PEGs Market Research Report 2025
Pharmaceutical Grade Polyethylene Glycol PEG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Grade Polyethylene Glycol PEG Market Research Report 2024
Global PEGylation Market Research Report 2024
Global Pharmaceutical Grade PEG 400 Market Research Report 2024
Global PEG Derivatives Market Research Report 2024
Global PEG Hydrogel based Medical Device Market Research Report 2024
Global Polyethylene Glycol 6000 Market Research Report 2025
Global Monodisperse Polyethylene Glycol Derivativesme Market Research Report 2024
Global PEG PPG Copolymers Market Research Report 2024
Global PEGylated Proteins Market Insights Forecast to 2030
Global Activated Polyethylene Glycol PEG Market Insights Forecast to 2030
Polyethylene Glycol PEG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions